Table 2.
All patients (n = 301) | Disease severity | p value a | |||
---|---|---|---|---|---|
Mild (n = 186) | Severe (n = 87) | Critical (n = 28) | |||
Leucocytes, per μl | 5480 (4400–7490) | 5300 (4450–7020) | 5620 (4280–8360) | 7280 (47,80–103,30) | 0.065 |
Neutrophils, per μl | 3550 (2760–5000) | 3370 (2680–4450) | 3720 (2730–5330) | 6280 (4070–8120) | 0.001 |
Neutrophil percentage, % | 64.1 (57.35–71.91) | 62.4 (57.25–67.50) | 63.6 (56.6–72.2) | 89.95 (83.85–94.15) | 0.001 |
Lymphocytes, per μl | 1440 (1020–1820) | 1580 (1230–1890) | 1190 (890–1690) | 785 (530–900) | 0.001 |
Lymphocyte percentage, % | 26.2 (19.35–33.30) | 27.8 (23.9–34.01) | 26.11 (16.45–33.82) | 4.65 (3.17–14.3) | 0.001 |
Monocyte, per μl | 460 (330–650) | 470 (330–620) | 500 (390–780) | 240 (140–520) | 0.001 |
Monocyte percentage, % | 7.9 (6.5–10.15) | 7.8 (6.5–10.0) | 9.1 (7.52–10.97) | 4.25 (2.02–5.51) | 0.001 |
NLR | 2.46 (1.77–4.09) | 2.1 (1.66–3.04) | 2.95 (1.80–4.63) | 8.78 (4.63–17.61) | 0.001 |
Data were presented as median (IQR).
aComparison among mild, severe, and critical groups.